跳至主要内容
临床试验/NCT05853783
NCT05853783招募中不适用

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Proteocyte Diagnostics Inc.5 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
180
试验地点
5
主要终点
Sensitivity and Specificity

研究概览

简要总结

The purpose of this study is to validate the ability of the STRATICYTE™ predictive model to predict the transformation of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC) in a retrospective cohort of patients who received biopsies.

详细描述

The study objectives are to:

  1. Evaluate STRATICYTE™ sensitivity and specificity in a cohort of patients that meet the inclusion/exclusion criteria.
  2. Identify patient and clinical characteristics influencing the sensitivity and specificity of the STRATICYTE™ model.
  3. Estimate the correlation between STRATICYTE™ outcome and time to a positive diagnosis of oral cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • From the archive, any patient who presents with clinically evident oral lesions and biopsy-proven dysplasia (punch or scalpel biopsies; any grade or classification system)
  • Patients with initial oral lesions with epithelial atypia suspicious for neoplasia, with:
  • No histological evidence of cancer with clinical follow-up data for a period of at least five years; or
  • OSCC development (histologic or documented evidence of invasive cancer).
  • Patients who had archived biopsy tissue blocks of a previous oral lesion(s) meeting the above criteria and retained at the same clinical center.

排除标准

  • Patients with oral lesions or dysplasia with no indication of OSCC development or follow-up data of less than five years in non-OSCC patients.
  • Patients diagnosed with oral epithelial dysplasia concomitant with OSCC at the time of the biopsy's original pathology report or a subsequent clinical note of cancer progression within three months post-biopsy.

结局指标

主要结局

Sensitivity and Specificity

时间窗: 5 years

Standard measures of accuracy calculated using cross-tabulation of predicted risk category and confirmed cancer progression over a 5-year period from biopsy

Survival analysis

时间窗: 5 years

Kaplan-Meier analyses to compare time to a positive diagnosis of oral cancer between patients/biopsies with a STRATICYTE™ classification of Low- and Elevated-Risk.

次要结局

  • AUC(5 years)
  • C-index (Harrell's)(5 years)

研究者

发起方
Proteocyte Diagnostics Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Evaluation of Oral Potentially Malignant Disorders... | 临床试验